Table 2. Cardiac work up.
Echocardiography | N = 25 |
LVEF (%) | 54.1±9.0 |
LVEDD (mm) | 46.7±5.9 |
RV-function, normal | 23 (92%) |
RV-function, moderately impaired | 1 (4%) |
RV-function, severely impaired | 1 (4%) |
RVEDD (mm) | 31.3±5.3 |
Systolic PAP (mmHg) | 36.1±13.1 |
Right heart catheterization | N = 25 |
PAmean (mmHg) | 21.1±8.7 |
Pulmonary function test | N = 25 |
FVC (l) | 3.1±1.1 |
FVC (%) | 70.8±20.7 |
24h-Holter Recording | N = 18 |
No ventricular ectopy | 6 (33%) |
Couplets and triplets | 7 (39%) |
Ventricular salvos or nsVTs | 5 (28%) |
Results of endomyocardial biopsies | |
Degree of inflammation | N = 25 |
No inflammation | 1 (3.8%) |
Single inflammatory cells | 10 (38.5%) |
Some foci of inflammation | 8 (30.8%) |
Several foci of inflammation | 4 (15.4%) |
Pronounced inflammation | 2 (7.7%) |
Immunohistology | N = 25 |
CD3 | 14 (56%) |
CD68 | 19 (76%) |
MHC II | 20 (80%) |
Virus positive | N = 25 |
EV | 1 (4%) |
PVB19 | 2 (8%) |
EBV | 2 (8%) |
HHV 6 | 1 (4%) |
Values are n (%) or mean±standard deviation. CD – cluster of differentiation, EV – enteroviruses, EBV – Epstein-Barr virus, FVC – functional vital capacity, h – hour, HHV 6 – Human herpesvirus 6, LVEDD – left ventricular enddiastolic diameter, LVEF—left ventricular ejection fraction, MHC II – major histocompatibility complex class II, mm – milimeters, mmHg – milimeters of mercury, nsVTs—non sustained ventricular tachycardia, PAmean—mean pulmonary arterial pressure measured in right heart catheterization, PAP—pulmonary artery pressure,in echocardiography, PVB19—Parvovirus B19, RV—right ventricular, RVEDD – right ventricular enddiastolic diameter, VES – ventricular extrasystoles. *Continuous variables were compared using t- test, categorical data were analyzed by chi-square test.